Navigation Links
Australia's Leading Oncology Drug Compounder Chooses RIVA System
Date:2/11/2009

WINNIPEG, Feb. 11 /PRNewswire/ - Pharmatel Fresenius Kabi Pty Ltd, one of Australia's fastest growing and most innovative pharmaceutical companies, has chosen the RIVA System (Robotic IV Automation) - a self-contained unit for filling IV syringes and bags - from Intelligent Hospital Systems (IH Systems) to consolidate its IV preparation. Pharmatel Fresenius Kabi will take delivery of its first RIVA unit in June 2009.

The RIVA System and Pharmatel Fresenius Kabi's continued investment in specialized sterile facilities are a perfect match for meeting the needs of leading-edge oncology care providers, according to Kevin McGarry, Chief Executive Officer of IH Systems. "With two Therapeutic Goods Administration (TGA) registered aseptic compounding facilities preparing tailor-made chemotherapy doses each day, Pharmatel Fresenius Kabi knows this field and knows that the RIVA System is able to meet its very high standards," says Mr. McGarry. He continues, "We are thrilled to be working with this specialist company in oncology care.

As the demands for improving patient care and safety increase, health care facilities are increasingly seeking technologically advanced, cost efficient solutions, says Jane Arnot, Vice President of Sales and Marketing with IH Systems. "One of the many attributes of the RIVA System that makes it so attractive is its flexibility to support the diverse needs of Pharmatel Fresenius Kabi's clients," shares Ms. Arnot. "The RIVA System is well suited to compounding individual patient doses of oncology drugs into a range of diverse container forms including syringes and bags, which is key to supporting convenient and flexible therapy."

Limitations in conventional clean room technology have provided challenges for manufacturers of compounded oncology products, says Iain Rosekilly, Operations Director of Pharmatel Fresenius Kabi. "Since we identified the RIVA system, Intelligent Hospital Systems has worked tirelessly with us to develop the technology to fit our business model. Their flexible and customer centred approach will ensure the successful roll out and implementation of the project." Mr. Rosekilly continues, "IV Robotics have the ability to address our market growth requirements, as well as many of the important safety aspects involved in the aseptic compounding of IV drugs, this would include increased patient safety by the elimination of dose errors, furthermore providing increased technician operator safety, RSI and other OH& S factors."

RIVA (Robotic IV Automation System) - a self-contained unit for filling IV syringes and bags - is the first product developed by Winnipeg-based medical device company Intelligent Hospital Systems. For more information, please visit www.rivasystem.com.


'/>"/>
SOURCE Intelligent Hospital Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Research and Markets ... Electronics 2015-2025: Applications, Technologies, Forecasts" report to ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, Composite ... Structural electronics involves electronic and/or electrical components and ... dumb structures such as vehicle bodies or conformally ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: